Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Thyroid Hormone Receptor
100%
Receptor Antagonist
100%
Nuclear Receptor
100%
In Silico Modeling
100%
Prostacyclin
100%
Lipid Mediators
100%
GW0742
60%
Beraprost Sodium
60%
PGI2
40%
Vasodilation
20%
IC50
20%
Peroxisome Proliferator-activated Receptor
10%
Receptor Subtypes
10%
Peroxisome Proliferator-activated Receptor Agonists
10%
Cell Surface
10%
Chemistry Method
10%
Short Half-life
10%
Pharmacological Methods
10%
Long-term Function
10%
Computational Chemistry
10%
Rat Mesenteric Artery
10%
Receptor-ligand Binding
10%
Wire Myograph
10%
Triiodothyronine
10%
Allosteric Control
10%
Luciferase Reporter Assay
10%
Antagonistic Properties
10%
In Silico Screening
10%
Cardiovascular Homeostasis
10%
Direct Method
10%
IP Receptor Agonist
10%
IP Receptor
10%
Binding Profile
10%
Ligand Binding Site
10%
Docking Analysis
10%
Biochemistry, Genetics and Molecular Biology
Mediator
100%
Lipid
100%
Nuclear Receptor
100%
Receptor Antagonist
100%
Thyroid Hormone Receptor
100%
Prostacyclin
100%
Beraprost
60%
Vasodilatation
20%
IC50
20%
Homeostasis
10%
Allosteric Regulation
10%
PPAR Agonist
10%
Peroxisome Proliferator-Activated Receptor
10%
Binding Site
10%
Ligand Binding
10%
Receptor Agonists
10%
Triiodothyronine
10%
Luciferase
10%
Liothyronine
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cell Nucleus Receptor
100%
Thyroid Hormone Receptor
100%
Hormone Receptor Blocking Agent
100%
Prostacyclin
100%
Beraprost
60%
[4 [2 (3 Fluoro 4 Trifluoromethylphenyl) 4 Methyl 5 Thiazolylmethylthio] 2 Methylphenoxy]acetic Acid
60%
IC50
20%
Receptor
20%
Peroxisome Proliferator Activated Receptor
10%
PPAR Agonist
10%
Binding Site
10%
Luciferase
10%
Receptor Agonist
10%
Liothyronine
10%